Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Plasmovita is managing 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. AZUBUOGU, CHIEMERIE CHIBUZOR is the busiest examiner, currently overseeing 1 pending office action. The company's active prosecution is limited to this 1 action, indicating a specific technical focus. This single matter in 1 art unit represents the total current engagement with the patent office, reflecting a targeted strategy in the medical devices sector.
The concentration of the company's current prosecution under 1 distinct examiner allows for a direct and singular focus. AZUBUOGU, CHIEMERIE CHIBUZOR is the only individual at the patent office currently reviewing the company's pending work. This 1 pending office action is being evaluated within 1 distinct art unit, meaning the company must meet the specific technical requirements of that specialized group. Because there is only 1 action, the company's immediate patenting success depends on the outcome of this single review. This focused activity defines the present state of the company's interaction with the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AZUBUOGU, CHIEMERIE CHIBUZOR | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18856199 | IMMEDIATELY LOADED INTRAOSSEOUS SCREW IMPLANT AND ITS INSTALLATION METHOD | AZUBUOGU, CHIEMERIE CHIBUZOR | — |
| Art Unit | Apps |
|---|---|
| 3772 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18856199 | IMMEDIATELY LOADED INTRAOSSEOUS SCREW IMPLANT AND ITS INSTALLATION METHOD | AZUBUOGU, CHIEMERIE CHIBUZOR | 3772 | §102§103§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPlasmovita has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Chiemerie Chibuzor Azubuogu has the most, with 1 of Plasmovita's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
